Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 May;10(5):345-52.
doi: 10.1038/nri2747.

Strategies and challenges for the next generation of therapeutic antibodies

Alain Beck  1 , Thierry Wurch, Christian Bailly, Nathalie Corvaia
Affiliations
Review

Strategies and challenges for the next generation of therapeutic antibodies

Alain Beck et al. Nat Rev Immunol. 2010 May.

Abstract

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain insights into the successful strategies used by pharmaceutical companies so far to bring innovative drugs to the market. Many challenges will have to be faced in the next decade to bring more efficient and affordable antibody-based drugs to the clinic. Here, we discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with additional functions.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nature. 1990 Dec 6;348(6301):552-4 - PubMed
    1. Expert Opin Drug Discov. 2010 Jan;5(1):95-111 - PubMed
    1. N Biotechnol. 2009 Jun;25(5):280-6 - PubMed
    1. Nat Rev Drug Discov. 2010 Feb;9(2):89-92 - PubMed
    1. Immunotherapy. 2009 Mar;1(2):265-79 - PubMed

LinkOut - more resources